Sanbioinc Also Known As Sanbio Co Ltd Is A Biotechnology Company Based In Chuo Kutokyojapanthe Company Focuses On Developingproducingand Selling Regenerative Cell Medicinesparticularly For Neurological Disorders Such As Stroketraumatic Brain Injurytbi And Parkinson S Disease Sanbio Specializes In Innovative Regenerative Cell Therapies Using Modified Adult Bone Marrow Derived Mesenchymal Stem Cellstheir Flagship Productsb623Is An Investigational Treatment For Chronic Deficits Resulting From Ischemic Stroke And Tbiother Products In Development Include Sb618 For Peripheral Nerve Damagesb308 For Muscle Dystrophymsc1 For Cancer Treatmentand Msc2 For Inflammatory Diseasessanbio Develops These Drug Candidates Internally And May Out License Them To Larger Pharmaceutical Companies For Further Development The Company Operates In Several Countriesincluding The United Statesjapanand Ukrainewith Its Headquarters In Tokyosanbio Has Made Significant Progressincluding Obtaining Marketing Approval For Sb623 For Chronic Tbi In Japan And Securing New Patents For Its Cell Therapy In The U S
